Skip to main content

Shell Asset Management Co

SEC CIK
0001211028
Latest filing
Nov 7, 2025

BNGO holding history

Bionano Genomics, Inc. in every 13F filed by Shell Asset Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BNGO overviewAll 13F holders of BNGOFull Q3 2025 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
8
Since Q2 2021
Holdings of BNGO by Shell Asset Management Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−12,262−100.0%Sold outHolders
Q1 202312,262$14.0K<0.1%−44−0.4%ReducedHolders
Q4 202212,306$18.0K<0.1%−838−6.4%ReducedHolders
Q3 202213,144$24.0K<0.1%−1,324−9.2%ReducedHolders
Q2 202214,468$20.0K<0.1%+77+0.5%AddedHolders
Q1 202214,391$37.0K<0.1%−2,259−13.6%ReducedHolders
Q4 202116,650$50.0K<0.1%−153−0.9%ReducedHolders
Q3 202116,803$92.0K<0.1%−670−3.8%ReducedHolders
Q2 202117,473$128.0K<0.1%+17,473NewHolders